Skip to main content
. 2021 Sep 24;13(19):4775. doi: 10.3390/cancers13194775

Table 2.

SBRT for spine and brain metastasis in soft tissue sarcoma.

Study Treated Site Number of Patients Number of Treated Lesions 12-Month LC (%) 12-Month OS (%)
Folkert et al., MSKCC [39] Spine 88 120 87.9 60.6
Bishop et al., MDACC [41] Spine 48 66 81 67
Sim et al., Moffit [44] Brain 24 58 89 38
Flannery et al., Pittsburgh [45] Brain 21 60 88 60

LC: local control; OS: overall survival.